February 16, 2017
e-Therapeutics’s Executive Director & Company Secretary leaves
e-Therapeutics’s Executive Director & Company Secretary Sean Nicolson is leaving the company in order to focus on other business commitments.
pharmaceutical daily
Pharmaceuticals, Biotechnology and Life Sciences
February 16, 2017
Denovo plans on restarting DB102 trial, in China and US
Denovo Biopharma’s new clinical center in China opened last year will play a very important role in the biomarker driven DB102 trial, as the company has submitted the IND application to the China FDA.
February 16, 2017
Active Biotech reduces its net loss in 2016
Active Biotech has reported net loss of € 1,6 million for Q4, which is decrease of loss comparing to the same period 2015 when the net loss was € 4,3 million.
February 16, 2017
Weifa triples its net income for 2016
Weifa ASA, Norwegian health company has reported net income of € 0,9 million for Q4 2016 which is increase comparing to the same period last year when the comapany had € 0,3 million loss. The company has more than tripled its net income for year 2016. It has reported € 2,03 million for whole 2016 and net income for the 2015 was € 0,65 million.
February 16, 2017
Vectura achieves royalty cap from GSK’s respiratory products
Vectura Group has reached a royalty cap on net sales of £9 million from selling GSK’s respiratory Ellipta products in 2016.
February 16, 2017
Baxter International adds ENFit to its portfolio
Baxter International, the company focused on nutrition therapy, has expand its nutrition care portfolio to include the new enteral ENFit syringe and accessory line for patients requiring tube feeding.
February 16, 2017
Pharma companies to grow overseas sales regionally at CPhI South East Asia
The slowing pace of global markets and the increasing threat of a new protectionist wave is transforming the outlook of South East Asian manufacturers, which are now shifting their focus towards regional exports. Mirroring this trend, international investors and companies are increasingly looking at more business access in Indonesia and across the entire ASEAN economy.
February 15, 2017
Surrozen secures $33 million through Series A financing to fund its research of Wnt signaling in regeneration
A newly formed biopharmaceutical company based in San Francisco, USA, has ensured funds for unlocking research of the therapeutic potential of Wnt signaling, a key for stem-cell maintenance and tissue regeneration.
February 15, 2017
Pharma industry shuns Trump push for radical shift at FDA
U.S. President Donald Trump’s vow to roll back government regulations at least 75 percent is causing anxiety for some pharmaceutical executives that a less robust Food and Drug Administration would make it harder to secure insurance coverage for pricey new medicines.
February 15, 2017
Adocia’s revenue for 2016 down 40% year over year, develops Lispro on its own after Lilly’s deal break-up
Adocia plans to license its diabetes treatment products, especially its most advanced program BioChaperone Lispro. The company’s boss said that cash position of €58 million will enable the company to push BioChaperone Lispro into phase 3 clinical trial.